Hopes rise for mRNA cancer vaccine after Moderna trial shows promise

Pharma company Moderna made a significant announcement this week, revealing that its mRNA cancer vaccine, initially designed for melanoma, shows potential in treating head and neck cancer as well. This development represents a milestone in expanding the application of mRNA technology beyond COVID treatments. Moderna’s revelation caused a surge in its stock price, highlighting […]

April 14, 2024

Artificial intelligence reveals prostate cancer is not just one disease

Research published in Cell Genomics has unveiled a groundbreaking discovery about prostate cancer, a disease affecting one in six men in the UK during their lifetime. This study, conducted by an international consortium including researchers from the University of Oxford, the University of Manchester, the University of East Anglia, and the Institute of Cancer Research, […]

March 26, 2024

A new AI-based risk prediction system could help catch deadly pancreatic cancer cases earlier

A groundbreaking project led by MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL) and the Beth Israel Deaconess Medical Center has developed a cutting-edge AI system, PRISM, that predicts an individual’s likelihood of developing pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer. The system, utilizing artificial neural networks and an algorithmic […]

January 20, 2024

Scientists tame chaotic protein fueling 75% of cancers

The battle against cancer received a significant boost as UC Riverside researchers have made a groundbreaking discovery in taming the infamous MYC protein, known to exacerbate 75% of human cancer cases. At the heart of their discovery lies a peptide compound that effectively binds to and suppresses the activity of MYC, offering a glimmer of […]

January 14, 2024

MIT experts develop AI models that can detect pancreatic cancer early

Researchers at MIT’s CSAIL have developed a machine learning algorithm, “PRISM,” which can detect pancreatic cancer at a higher threshold than current diagnostic standards. PRISM was programmed based on access to diverse sets of real electronic health records from health institutions across the US, using the data of over 5 million patient’s electronic health […]

January 12, 2024

Dog cancer treatment ImpriMed aims to expand its AI technology into human oncology

ImpriMed, a precision medicine startup, has developed AI-powered technology for personalized drug efficacy prediction in canine and feline blood cancers. The company now aims to expand its technology to human oncology applications. ImpriMed recently closed a $23 million Series A funding and has been partners with SK Telecom. Their B2B service involves collecting live cancer […]

December 19, 2023

Anti-Cancer Pill Shows Promising Results in Human Experiment

Researchers at the Peter MacCallum Cancer Center in Australia have found that a drug called divarasib, when combined with another treatment called cetuximab, shows promising results in treating a specific form of bowel cancer caused by a mutation in the KRAS gene. The combination resulted in a positive outcome for 62 percent of patients, with […]